BillionToOne (BLLN) vs CareDx (CDNA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
BillionToOne is the larger company by market cap ($4.52 billion vs $3.26 billion), about 1.4 times the size. On valuation, CareDx trades at a lower forward P/E (48.9x vs 64.5x for BillionToOne).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLLN | CDNA |
|---|---|---|
| Share price | $95.75 | $63.04 |
| Market cap | $4.52B | $3.26B |
| 1-day change | -4.19% | -1.18% |
| YTD return | +17.00% | +234.61% |
| 1-year return | — | +329.72% |
| 5-year return | — | -11.21% |
| P/E ratio (TTM) | 151.98 | 30.31 |
| Forward P/E | 64.48 | 48.87 |
| EPS (TTM) | $0.63 | $2.08 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $305.11M | — |
| Revenue growth (YoY) | +99.97% | — |
| Net income (latest FY) | $7.45M | — |
| Gross margin | 68.32% | — |
| Operating margin | 5.25% | — |
| Net margin | 2.44% | — |
| 52-week high | $150.44 | $72.51 |
| 52-week low | $61.96 | $13.95 |
| Distance from 52-week high | -36.35% | -13.06% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +34.73% | -6.68% |
| Average volume | 696.69K | 1.28M |
| Shares outstanding | 42.64M | 51.73M |
| Employees | 713 | 761 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BillionToOne trades at a higher earnings multiple (152.0x vs 30.3x trailing P/E).
About BillionToOne
BLLN stock →BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection.
Health Care · Medical Specialities · 713 employees
About CareDx
CDNA stock →CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
Health Care · Medical Specialities · 761 employees
BLLN vs CDNA FAQ
Which is bigger, BillionToOne or CareDx?
BillionToOne (BLLN) is larger, with a market capitalization of $4.52B compared with $3.26B for CareDx (CDNA).
Which has the lower P/E ratio, BLLN or CDNA?
CDNA has the lower trailing P/E at 30.3, versus 152.0 for BLLN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are BillionToOne and CareDx in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.